Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should screening MRI be included in surveillance for patients treated with breast-conserving therapy?

Nature Clinical Practice Oncology volume 6, pages 8–9 (2009)Cite this article

Abstract

Breast MRI has been shown to provide diagnostic benefit in multiple situations. It has proved useful in the evaluation of ruptured silicone implants and in the evaluation of patients with cancerous axillary lymph nodes, a negative mammogram and unremarkable physical examination. Gorechlad et al. carried out a retrospective study designed to determine whether MRI has a role in screening for cancer recurrence in patients treated with breast-conserving therapy. As the results showed that the recurrence rate and risk of contralateral disease were both very low, the authors concluded that MRI screening would not have been cost-effective and was unlikely to have improved overall survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Saslow D et al. (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57: 75–89

    Article  Google Scholar 

  2. Bigenwald RZ et al. (2008) Is mammography adequate for screening women with inherited BRCA mutations and low breast density? Cancer Epidemiol Biomarkers Prev 17: 706–711

    Article  CAS  Google Scholar 

  3. Gorechlad JW et al. (2008) Screening for recurrences in patients treated with breast-conserving surgery: is there a role for MRI? Ann Surg Oncol 15: 1703–1709

    Article  Google Scholar 

  4. Fisher B et al. (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16: 441–452

    Article  CAS  Google Scholar 

  5. Warner E et al. (2004) Surveillance Of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292: 1317–1325

    Article  CAS  Google Scholar 

  6. Solin LJ et al. (2008) Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26: 386–391

    Article  Google Scholar 

  7. Fischer U et al. (2004) The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14: 1725–1731

    Article  Google Scholar 

  8. Lehman CD et al. (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356: 1295–1303

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. M Rebner is Co-Director of the Division of Breast Imaging and Intervention, and I Grills is the Radiation Oncology Residency Program Director and chair of the Multi-Disciplinary Breast Tumor Conference, both at William Beaumont Hospital, Royal Oak.,

    Murray Rebner & Inga Grills

  2. F Vicini is Chief of Oncology and Clinical Professor at Beaumont Cancer Institute, Royal Oak, MI, USA.,

    Frank Vicini

Authors
  1. Murray Rebner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Inga Grills
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frank Vicini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank Vicini.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rebner, M., Grills, I. & Vicini, F. Should screening MRI be included in surveillance for patients treated with breast-conserving therapy?. Nat Rev Clin Oncol 6, 8–9 (2009). https://doi.org/10.1038/ncponc1277

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1277

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing